tiprankstipranks
Trending News
More News >
Denali Therapeutics (DNLI)
NASDAQ:DNLI

Denali Therapeutics (DNLI) Revenue

Compare
794 Followers

Denali Therapeutics Revenue

Denali Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Denali Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
443
Market Cap
$2.81B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
-330.53M
Dec 31, 2023
330.53M222.07M+304.74%
Dec 31, 2022
108.46M59.80M+222.90%
Dec 31, 2021
48.66M-287.00M+14.50%
Dec 31, 2020
335.66M308.98M+1,258.19%
Dec 31, 2019
26.68M-102.48M+20.66%
Dec 31, 2018
129.16M-12,916,000,000.00%
Dec 31, 2017
Dec 31, 2016